Abstract
Licari and colleagues detected plasma pentraxin 3 (PTX3) and serum D‐dimer levels, and reported significant elevated concentrations for both biomarkers in asthmatic patients compared with healthy controls, but neither was observed to be associated with clinical parameters.
Elevated PTX3 expressions in asthmatic airways were firstly observed by Zhang et al,1 and the same group reported that PTX3 deletion enhanced airway inflammation, mucus production, and airway hyperresponsiveness in an ovalbumin‐induced asthma model through a TH17‐dominant phenotype.2
This article is protected by copyright. All rights reserved.
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2t4Kgkg
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.